Please contact the EASI-Genomics Transnational Access Call managers for general inquiries, project consultation and guidance on ethics requirements.
Your request will be directed to the appropriate facility leaders or ELSI experts. For project consultation, you may also reach out to the EASI-Genomics partner facilities directly.
3rd Call for Proposals for Transnational Access Projects at the European Advanced infraStructure for Innovative Genomics (EASI-Genomics)
Update March 2, 2021:
- "Begin a new proposal" has been fixed.
- "File upload" is still disabled - Please mail any required documents to email@example.com while the file upload function is disabled. Please include your PID in the subject line of your email.
Call open: 15.01.2021 8:00 CET
Proposal submission deadlines: 08.03.2021 23:59 CET
Notification to applicants: by 01.07.2021
Start of projects: latest 6 months after notification
EASI-Genomics is a European Genomics Infrastructure Horizon 2020 project. This novel infrastructure supports researchers in next-generation sequencing and other high-end genomics applications and genomic data analysis. The infrastructure is accessible worldwide to academic researchers, research groups and scientific institutions. Furthermore, projects from industry, including SMEs will be supported. Throughout four calls for access, EASI-Genomics will support more than 150 projects for a total budget of 6 million € until the end of 2022. The first two access calls and an extraordinary call in response to the COVID-19 crisis awarded a total of 72 projects for a total budget of appr. 4 million €. The rules of the European Commission only allow Transnational Access; applicants will not be granted access to a facility that is in their home country.
EASI-Genomics will support integrative projects covering expertise that is not available at the applicants’ home institution sites including high-throughput and cutting-edge sequencing, complex bioinformatic analysis and possibly DNA extraction (e.g. ancient DNA). Of note, EASI-Genomics also provides data analysis for already existing data sets. In this case, applicants should describe available data including sequencing technology used to generate it and the objective of the analysis. Costs of external user projects for consumables and for personnel required at the facilities will be covered by EASI-Genomics.
EASI-Genomics invites external users to apply for access by opening several calls for proposals. Interested users can submit proposals to the 3rd Call online via the EASI-Genomics website (https://www.easi-genomics.eu/access/calls) until 1st of March, 2021, 23:59 CET. EASI-Genomics can provide guidance for such documentation. As pilots to Horizon Europe we encourage project applications with a focus on the mission areas (e.g. cancer, soil health and food). Applicants will be asked to describe the objectives of their research and the desired experimental and computational methods required to achieve these objectives. Valid ethical and legal documents relative to the research proposal will have to be submitted directly online at the time of submission by the applicant. Eligible proposals will be evaluated for scientific quality, feasibility, and impact. Proposals will be handled confidentially. EASI-Genomics recommends external users to contact the facilities offering the services of interest in order to discuss the feasibility of the submitted project prior to the submission of the proposal.
Details on the submission process, eligibility and evaluation criteria, and project implementation can be found at www.easi-genomics.eu
Topics of the third call for proposals:
i) Sequencing of ancient DNA.
EASI-Genomics offers to sequence ancient DNA at its state-of-the-art equipped facilities with special expertise in DNA isolation and sample preparation from challenging specimens. Applicants need to provide a detailed description of the objectives of their project, available sample materials, and explain wet-lab and/or computational procedures required for the execution of the project.
ii) Single-cell genomics.
EASI-Genomics will support projects that require advanced single-cell multi-omics analysis. Techniques such as single-cell-3´- or 5’-tag RNA sequencing, feature-barcoding, full-length transcript sequencing, B- and T-cell receptor profiling, ATAC-Seq, or combinations thereof are available. Applicants need to provide a detailed description of the objectives of their project and explain wet-lab and/or computational procedures required for the execution of the project. Applicants need to describe sample material in detail, such as availability, viability, biosafety containment level, storage conditions.
iii) Spatial transcriptomics/in situ sequencing.
Recent advances in RNA sequencing technology enable the profiling of cellular gene expression heterogeneity at spatial resolution. EASI Genomics offers spatial transcriptomics and in situ sequencing for the investigation of spatial tissue organization. Applicants need to provide a detailed description of the objectives of their project and explain wet-lab and/or computational procedures required for the execution of the project. Applicants need to describe available sample material in detail.
iv) Identification of epigenetic signatures.
EASI Genomics offers technologies for profiling of epigenetic signatures such as DNA methylation, chromatin accessibility, or chromatin 3D-structure. Projects should focus on specific tissue/cell types to decipher epigenetic signatures with mechanistic relevance for human disease or ecologically and/economically relevant species. Studies analyzing surrogate epigenetic markers (e.g. blood-derived) are advised against. Applicants need to provide a detailed description of the objectives of their project and explain wet-lab and/or computational procedures required for the execution of the project. Applicants need to describe available sample material in detail.
v) Long-read sequencing with Oxford Nanopore Technology.
We seek for the following applications: long-read genome sequencing, de novo assembly and annotation, structural variant detection, metagenomics, full-length mRNA and cDNA sequencing. The projects should focus on human disease or on ecologically and/economically relevant species. Procedures available at EASI-Genomics laboratories for these projects are Oxford Nanopore long-read DNA and RNA sequencing and state-of-the-art data analysis support. Applicants need to provide a detailed description of the objectives of their project and explain wet-lab and/or computational procedures required for the execution of the project. Applicants need to describe available sample material in detail.
vi) FFPE RNA and exome sequencing.
Formalin-fixed paraffin embedded (FFPE) samples are the most abundant source of archived clinical specimens, but pose distinct challenges for nucleic acid isolation and analysis. Our specialized facilities offer RNA and exome sequencing from FFPE samples to enable projects based on archived material. Applicants need to provide a detailed description of the objectives of their project, provide information about the available sample materials such as fixation conditions and storage times, and explain wet-lab and/or computational procedures required for the execution of the project.
Cross-topic applications are supported.
For general inquiries and guidance on ethical documentation, please contact the call managers at firstname.lastname@example.org. For project consultation, you may either reach out to the TNA call managers or contact the EASI-Genomics partner facilities directly. Contact details are available in the Third TNA Call Topics Description.